Compare Dr. Reddys with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs SUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB SUN PHARMA DR. REDDYS LAB/
SUN PHARMA
 
P/E (TTM) x 48.4 30.3 159.5% View Chart
P/BV x 4.6 4.0 116.2% View Chart
Dividend Yield % 0.5 1.0 52.8%  

Financials

 DR. REDDYS LAB   SUN PHARMA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-21
SUN PHARMA
Mar-21
DR. REDDYS LAB/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs5,515654 843.6%   
Low Rs3,028339 894.1%   
Sales per share (Unadj.) Rs1,145.4139.6 820.4%  
Earnings per share (Unadj.) Rs114.59.5 1,202.1%  
Cash flow per share (Unadj.) Rs188.418.2 1,035.5%  
Dividends per share (Unadj.) Rs25.007.50 333.3%  
Avg Dividend yield %0.61.5 38.7%  
Book value per share (Unadj.) Rs1,053.2193.6 543.9%  
Shares outstanding (eoy) m166.302,399.34 6.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.73.6 104.9%   
Avg P/E ratio x37.352.1 71.6%  
P/CF ratio (eoy) x22.727.3 83.1%  
Price / Book Value ratio x4.12.6 158.3%  
Dividend payout %21.878.8 27.7%   
Avg Mkt Cap Rs m710,2891,190,430 59.7%   
No. of employees `000NANA-   
Total wages/salary Rs m36,29968,622 52.9%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m190,475334,981 56.9%  
Other income Rs m2,9148,592 33.9%   
Total revenues Rs m193,389343,573 56.3%   
Gross profit Rs m38,69941,616 93.0%  
Depreciation Rs m12,28820,800 59.1%   
Interest Rs m9701,414 68.6%   
Profit before tax Rs m28,35527,994 101.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,3195,147 181.1%   
Profit after tax Rs m19,03622,847 83.3%  
Gross profit margin %20.312.4 163.5%  
Effective tax rate %32.918.4 178.8%   
Net profit margin %10.06.8 146.5%  
BALANCE SHEET DATA
Current assets Rs m145,503304,421 47.8%   
Current liabilities Rs m81,038161,456 50.2%   
Net working cap to sales %33.842.7 79.3%  
Current ratio x1.81.9 95.2%  
Inventory Days Days61149 41.2%  
Debtors Days Days9599 96.3%  
Net fixed assets Rs m109,979336,682 32.7%   
Share capital Rs m8322,399 34.7%   
"Free" reserves Rs m174,319462,229 37.7%   
Net worth Rs m175,151464,628 37.7%   
Long term debt Rs m6,2998,981 70.1%   
Total assets Rs m255,482641,103 39.9%  
Interest coverage x30.220.8 145.4%   
Debt to equity ratio x00 186.0%  
Sales to assets ratio x0.70.5 142.7%   
Return on assets %7.83.8 206.9%  
Return on equity %10.94.9 221.0%  
Return on capital %16.26.2 260.3%  
Exports to sales %51.30-   
Imports to sales %18.10-   
Exports (fob) Rs m97,699NA-   
Imports (cif) Rs m34,420NA-   
Fx inflow Rs m97,69984,493 115.6%   
Fx outflow Rs m34,42030,334 113.5%   
Net fx Rs m63,27954,159 116.8%   
CASH FLOW
From Operations Rs m35,70361,704 57.9%  
From Investments Rs m-22,6605,362 -422.6%  
From Financial Activity Rs m-298-59,805 0.5%  
Net Cashflow Rs m12,8585,964 215.6%  

Share Holding

Indian Promoters % 26.7 54.7 48.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 44.0 32.8 134.0%  
FIIs % 29.3 12.7 230.9%  
ADR/GDR % 14.0 0.0 -  
Free float % 59.2 45.3 130.7%  
Shareholders   131,498 653,359 20.1%  
Pledged promoter(s) holding % 0.0 6.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   NEULAND LABS  LAURUS LABS   FDC  PARENT.DRUGS  LASA SUPERGENERICS  



Today's Market

Sensex Jumps 400 Points to Hit Fresh Record High; Bajaj Finance & ITC Top Gainers(09:30 am)

Asian stock markets are trading on a steady note today as traders weighed risks from China to the global recovery and the prospect of reduced Federal Reserve stimulus.

Related Views on News

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider(Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore(Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

The Top Stocks to Sell in this Bull Market(Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Indian Companies that are Leading the AI Race(Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

Revenge Travel is Here. 9 Stocks Likely to Benefit(Views On News)

Sep 4, 2021

The term 'revenge travel' refers to the desire of going on a vacation after an extended period of lockdown.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Sep 17, 2021 12:08 PM

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 8-QTR ANALYSIS

COMPARE DR. REDDYS LAB WITH

MARKET STATS